174 related articles for article (PubMed ID: 27931149)
1. Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine.
Ma L; Wei S; Yang B; Ma W; Wu X; Ji H; Sui H; Chen J
Pharm Biol; 2017 Dec; 55(1):374-380. PubMed ID: 27931149
[TBL] [Abstract][Full Text] [Related]
2. Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome.
Wei S; Ji H; Yang B; Ma L; Bei Z; Li X; Dang H; Yang X; Liu C; Wu X; Chen J
Malar J; 2015 Nov; 14():432. PubMed ID: 26537009
[TBL] [Abstract][Full Text] [Related]
3. A self-contrast approach to evaluate the inhibitory effect of chrysosplenetin, in the absence and presence of artemisinin, on the in vivo P-glycoprotein-mediated digoxin transport activity.
Yang B; Ma LP; Ma W; Wei SJ; Ji HY; Li HG; Dang HW; Liu C; Wu XL; Chen J
Biomed Chromatogr; 2016 Oct; 30(10):1582-90. PubMed ID: 27012321
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
Horie K; Tang F; Borchardt RT
Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.
Saksena S; Goyal S; Raheja G; Singh V; Akhtar M; Nazir TM; Alrefai WA; Gill RK; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1115-23. PubMed ID: 21350189
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro.
Kim WY; Benet LZ
Pharm Res; 2004 Jul; 21(7):1284-93. PubMed ID: 15290871
[TBL] [Abstract][Full Text] [Related]
7. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.
Doricakova A; Theile D; Weiss J; Vrzal R
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):49-59. PubMed ID: 27678410
[TBL] [Abstract][Full Text] [Related]
9. 10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein.
Lee DH; Hasanuzzaman M; Kwon D; Choi HY; Kim SM; Kim DJ; Kang DJ; Hwang TH; Kim HH; Shin HJ; Shin JG; Oh S; Lee S; Kim SW
Curr Pharm Des; 2018; 24(46):5590-5597. PubMed ID: 30799787
[TBL] [Abstract][Full Text] [Related]
10. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
Patel J; Buddha B; Dey S; Pal D; Mitra AK
Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
12. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
[TBL] [Abstract][Full Text] [Related]
13. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
[TBL] [Abstract][Full Text] [Related]
14. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.
Eid SY; El-Readi MZ; Eldin EE; Fatani SH; Wink M
Phytomedicine; 2013 Dec; 21(1):47-61. PubMed ID: 23999162
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
16. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake.
Gutmann H; Fricker G; Török M; Michael S; Beglinger C; Drewe J
Pharm Res; 1999 Mar; 16(3):402-7. PubMed ID: 10213371
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp.
Li X; Hu J; Wang B; Sheng L; Liu Z; Yang S; Li Y
Toxicol Appl Pharmacol; 2014 Mar; 275(2):163-75. PubMed ID: 24380838
[TBL] [Abstract][Full Text] [Related]
18. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
19. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
20. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
